Legionella Testing Market Size, Share, Growth, Trends and Forecast 2024-2032

The global legionella testing market size reached US$ 308.5 Million in 2023. IMARC Group expects the market to reach US$ 578.0 Million by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032.

Legionella Testing Market Size, Share, Growth, Trends and Forecast 2024-2032

According to IMARC Group latest report titled” Legionella Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032”, offers a comprehensive analysis of the industry, which comprises insights on legionella testing market report. The report also includes competitor and regional analysis, and contemporary advancements in the global market.

The global legionella testing market size reached US$ 308.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 578.0 Million by 2032, exhibiting a growth rate (CAGR) of 7% during 2024-2032.

Legionella testing is a critical process used to detect the presence of Legionella bacteria, which can cause Legionnaires' disease, a severe form of pneumonia. Testing is vital for water system maintenance in various facilities, including hospitals, hotels, and commercial buildings. It involves collecting water samples and testing them using methods such as culture techniques, polymerase chain reaction (PCR), and serology. The types of testing vary from simple dip slides that provide a presence/absence result to more complex quantitative polymerase chain reaction (qPCR) methods that offer rapid and specific detection. The advantages of Legionella testing include safeguarding public health by preventing outbreaks, fulfilling legal compliance requirements, and maintaining the reputation of businesses that manage water systems. Regular testing is an aspect of water safety protocols. It is crucial for risk management in any facility with water systems that could harbor bacteria, such as cooling towers, hot water tanks, and complex plumbing systems.

Get a Sample Copy of this Report: https://www.imarcgroup.com/legionella-testing-market/requestsample

Market Trends:

The global Legionella testing market is majorly driven by escalating awareness of Legionnaires' disease and its implications for public health. An increase in the implementation of stringent regulations mandating regular water testing is a significant market driver, compelling facility managers to adopt routine Legionella monitoring practices. Along with this, technological advancements in testing methods are enhancing the accuracy and speed of detection, which, in turn, is propelling market growth. In addition, the trend towards automation in testing procedures is also a key factor, as it reduces the potential for human error and increases efficiency. Moreover, the growing hospitality and healthcare sectors are contributing to the rise in demand for Legionella testing services, given the high-risk nature of these environments. Apart from this, the global spread of Legionnaires' disease is prompting an urgent need for proactive testing measures, particularly in aging infrastructure where water systems are more vulnerable to bacterial growth. Furthermore, the evolution of international travel and the increased mobility of populations are creating a positive market outlook.

View Full Report with TOC & List of Figure: https://www.imarcgroup.com/legionella-testing-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

  • Abbott Laboratories
  • Becton
  • Dickinson and Company
  • bioMérieux SA
  • Bio-Rad Laboratories Inc
  • Eiken Chemical Co. Ltd
  • Quidel Corporation
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc

Legionella Testing Market Segmentation:

Our report has categorized the market based on region, application and end use industry.

Breakup by Application:

  • Water Testing
    • Microbial Culture
    • DFA Stain
    • PCR
    • Others
  • IVD Testing
    • Blood Culture
    • Urine Antigen Test
    • DFA Stain
    • PCR
    • Others

 Breakup by End User:

  • Hospitals and Clinics
  • Diagnostic Laboratory
  • Others

Breakup by Region:

  • North America (United States, Canada)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the report:

  • Market Performance (2018-2023)
  • Market Outlook (2024-2032)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow